Analysis of the Antiproliferative Effects of Curcumin and Nanocurcumin in MDA-MB231 as a Breast Cancer Cell Line

AuthorMohammad Hossein Khosropanahen
AuthorAmin Dinarvanden
AuthorAfsaneh Nezhadhosseinien
AuthorAlireza Haghighien
AuthorSima Hashemien
AuthorFereidon Nirouzaden
AuthorSepideh Khatamsazen
AuthorMaliheh Entezarien
AuthorMehrdad Hashemien
AuthorHossein Dehghanien
Issued Date2016-01-31en
AbstractCancer is one of the main causes of mortality in the world which appears by the effect of enviromental physico-chemical mutagen and carcinogen agents. The identification of new cytotoxic drug with low sid effects on immune system has developed as important area in new studies of immunopharmacology. Curcumin is a natural polyphenol with anti-oxidative, anti-inflammatory and anti-cancer properties. Its therapeutic potential is substantially hindered by the rather low water solubility and bioavailability, hence the need for suitable carriers. In this report we employed nanogel-based nanoparticle approach to improve upon its effectiveness. Myristic acid-chitosan (MA-chitosan) nanogels were prepared by the technique of self-assembly. Curcumin was loaded into the nanogels. The surface morphology of the prepared nanoparticles was determined using SEM and TEM. The other objective of this study was to examine the in vitro cytotoxic activity of cell death of curcumin and nanocurcumin on human breast adenocarcinoma cell line (MDA-MB231). Cytotoxicity and viability of curcumin and nanocurcumin were assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and dye exclusion assay.en
DOIhttps://doi.org/10.22037/ijpr.2016.1826en
KeywordAnticancer activityen
KeywordCurcuminen
KeywordNanocurcuminen
KeywordMTT assayen
KeywordHuman breast adenocarcinomaen
PublisherBrieflandsen
TitleAnalysis of the Antiproliferative Effects of Curcumin and Nanocurcumin in MDA-MB231 as a Breast Cancer Cell Lineen
TypeOriginal Articleen

Files